NICE Advice: The impact of the new cost effectiveness threshold
Tuesday 23rd June 2026 13:00 - 14:00 (BST)
Understand the implications: Explore how NICE’s new threshold changes could reshape pricing, access, launch strategy and innovation
Webinar Details:
Join John Spoors for this timely 60-minute webinar exploring the implications of NICE’s new cost-effectiveness threshold changes and what they could mean for the NHS and wider Life Sciences industry.
John will examine how recent trends in the UK pharmaceutical policy environment are shaping pricing and access policy.
John will also explore the potential unintended consequences for innovation, patient access and the UK’s attractiveness as a launch market, alongside the challenges facing companies operating across Rare Diseases, advanced therapies and other high-cost innovation areas.
Gain valuable insight into one of the most significant policy shifts affecting UK healthcare economics and market access strategy.
This is your opportunity to better understand how the evolving NICE landscape could shape future commercial and access decisions across the industry.
Key Learning Objectives:
- Understand the threshold changes – Learn what NICE’s revised cost-effectiveness thresholds mean for pricing, reimbursement and access decisions
- Explore the wider market impact – Examine how recent policy changes are influencing UK market access strategy
- Assess implications for innovation – Understand the potential impact on orphan medicines, advanced therapies and high-cost innovation
- Navigate launch strategy challenges – Explore how the evolving landscape could affect launch sequencing and UK market attractiveness
- Consider future policy implications – Gain insight into the potential unintended consequences for patient access, NHS priorities and industry decision-making
LSAA reserves the right to restrict access to this webinar to LSAA members.
-
Date and time
23rd Jun 2026 13:00 – 14:00 (BST)
